edoc

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

Bhadhuri, Arjun and Dröschel, Daniel and Guldimann, Mike and Jetschgo, Claudia and Banhazi, Judit and Schwenkglenks, Matthias and Sutherland, C. Simone. (2022) Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland. BMC Health Services Research, 22. p. 837.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/88702/

Downloads: Statistics Overview


Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Bhadhuri, Arjun and Schwenkglenks, Matthias
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Springer Nature
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:01 Jul 2022 15:14
Deposited On:01 Jul 2022 15:14

Repository Staff Only: item control page